Počet záznamů: 1  

Design, synthesis, and biological evaluation of novel 1,2-diaryl-4-substituted-benzylidene-5(4H)-imidazolone derivatives as cytotoxic agents and COX-2/LOX inhibitors

  1. 1.
    SYSNO ASEP0488993
    Druh ASEPJ - Článek v odborném periodiku
    Zařazení RIVJ - Článek v odborném periodiku
    Poddruh JČlánek ve WOS
    NázevDesign, synthesis, and biological evaluation of novel 1,2-diaryl-4-substituted-benzylidene-5(4H)-imidazolone derivatives as cytotoxic agents and COX-2/LOX inhibitors
    Tvůrce(i) Lamie, P.F. (EG)
    Philoppes, J.N. (EG)
    Rárová, Lucie (UEB-Q) RID, ORCID
    Celkový počet autorů3
    Číslo článkue1700311
    Zdroj.dok.Archiv der Pharmazie. - : Wiley - ISSN 0365-6233
    Roč. 351, 3-4 (2018)
    Poč.str.11 s.
    Jazyk dok.eng - angličtina
    Země vyd.DE - Německo
    Klíč. slovaanti-inflammatory ; cytotoxicity ; diaryl imidazolone derivatives ; molecular docking study
    Vědní obor RIVEB - Genetika a molekulární biologie
    Obor OECDBiochemical research methods
    CEPLO1204 GA MŠMT - Ministerstvo školství, mládeže a tělovýchovy
    Institucionální podporaUEB-Q - RVO:61389030
    UT WOS000428990000006
    EID SCOPUS85041582657
    DOI10.1002/ardp.201700311
    AnotaceA new series of 1,2-diaryl-4-substituted-benzylidene-5(4H)-imidazolone derivatives 4a–l was synthesized. Their structures were confirmed by different spectroscopic techniques (IR, 1 H NMR, DEPT-Q NMR, and mass spectroscopy) and elemental analyses. Their cytotoxic activities in vitro were evaluated against breast, ovarian, and liver cancer cell lines and also normal human skin fibroblasts. Cyclooxygenase (COX)-1, COX-2 and lipoxygenase (LOX) inhibitory activities were measured. The synthesized compounds showed selectivity toward COX-2 rather than COX-1, and the IC 50 values (0.25–1.7 µM) were lower than that of indomethacin (IC 50 = 9.47 µM) and somewhat higher than that of celecoxib (IC 50 = 0.071 µM). The selectivity index for COX-2 of the oxazole derivative 4e (SI = 3.67) was nearly equal to that of celecoxib (SI = 3.66). For the LOX inhibitory activity, the new compounds showed IC 50 values of 0.02–74.03 µM, while the IC 50 of the reference zileuton was 0.83 µM. The most active compound 4c (4-chlorobenzoxazole derivative) was found to have dual COX-2/LOX activity. All the synthesized compounds were docked inside the active site of the COX-2 and LOX enzymes. They linked to COX-2 through the N atom of the azole scaffold, while CO of the oxazolone moiety was responsible for the binding to amino acids inside the LOX active site.
    PracovištěÚstav experimentální botaniky
    KontaktDavid Klier, knihovna@ueb.cas.cz, Tel.: 220 390 469
    Rok sběru2019
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.